General Information of Drug (ID: DMF9T64)

Drug Name
Phthalic Acid Drug Info
Synonyms
Phthalic acid (tms); 1,2-Benzenedicarboxylic acid, bis(trimethylsilyl) ester; AC1LAT55; 2078-22-0; Phthalic acid, 2TMS derivative; Bis(trimethylsilyl) phthalate #; SCHEMBL16004864; Phthalic acid bis(trimethylsilyl); JUZOFKLPPHUUMC-UHFFFAOYSA-N; bis(trimethylsilyl) benzene-1,2-dicarboxylate; ORTHO-PHTHALIC ACID BIS(TRIMETHYLSILYL) ESTER
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
1017
ChEBI ID
CHEMBL1045
CAS Number
CAS 88-99-3
TTD Drug ID
DMF9T64

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Namn DM1EZ3N Discovery agent N.A. Investigative [1]
5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate DMGK05W Discovery agent N.A. Investigative [1]
Quinolinic Acid DM8YGOI Discovery agent N.A. Investigative [1]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [3]
Vidarabine DM0N85H Hepatosplenic T-cell lymphoma Approved [3]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [4]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [5]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [6]
Etidronic acid DM1XHYJ Bone Paget disease Approved [3]
Tiaprofenic acid DM23D7J Osteoarthritis FA00-FA05 Approved [3]
Bromperidol DM24XYQ Schizophrenia 6A20 Approved [3]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [7]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mycobacterium Nicotinate-nucleotide pyrophosphorylase (MycB nadC) TTH29K0 NADC_MYCTU Inhibitor [1]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Nuclear receptor subfamily 1 group I member 2 (NR1I2) OTC5U0N5 NR1I2_HUMAN Gene/Protein Processing [2]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol. 2005 May;19(5):1170-80.
3 Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
4 Induction of PXR-mediated metabolism by beta-carotene. Biochim Biophys Acta. 2005 May 30;1740(2):162-9. doi: 10.1016/j.bbadis.2004.11.013. Epub 2004 Dec 8.
5 Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol. 2005 Dec 1;209(2):123-33. doi: 10.1016/j.taap.2005.03.015.
6 Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening. Drug Metab Dispos. 2011 Feb;39(2):337-44. doi: 10.1124/dmd.110.035808. Epub 2010 Nov 10.
7 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
8 Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett. 2017 Jan 4;265:86-96.